Kim Eric S, Salgia Ravi
Section of Hematology/Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, Illinois 60637, USA.
J Thorac Oncol. 2009 Apr;4(4):444-7. doi: 10.1097/JTO.0b013e31819d6f91.
Dysregulation of mesenchymal-epithelial transition factor receptor tyrosine kinase pathway leads to cell proliferation, protection from apoptosis, angiogenesis, invasion, and metastasis. It can be dysregulated through overexpression, constitutive activation, gene amplification, ligand-dependent activation or mutation. New drugs targeting various mesenchymal-epithelial transition factor pathways are being investigated with promising results.
间充质-上皮转化因子受体酪氨酸激酶通路的失调会导致细胞增殖、抗凋亡、血管生成、侵袭和转移。它可通过过表达、组成性激活、基因扩增、配体依赖性激活或突变而失调。目前正在研究针对各种间充质-上皮转化因子通路的新药，且取得了有前景的结果。
